Patent · US Active

Nanoparticulate megestrol formulations

US9107827B2 · kind B2 · utility

2Cited by
81References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 7, 2014
Grant dateAug 18, 2015
Priority date
Expiry dateNov 7, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.